ENTEROEntero Healthcare Solutions Ltd.

₹1107.7-1.36%

Market Cap

₹4,877.78 Cr

Stock P/E

47.57

ROCE

9.16%

ROE

6.40%

Book Value

₹402.27

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Institution

Public

Others

From Last Concall

POSITIVES

•
FY25 was a milestone year with strong revenue, a large customer base, and profitability, followed by a positive operating cash flow in H2.
•
FY25 revenue grew 30% YoY with 16% organic growth, driven by IPM at 8%, translating to outperformance of the industry by ~2x.

NEGATIVES

•
Industry growth slowed in FY25, with the IPM industry growing around 8% for the year and ~7% in the last two quarters, underscoring cyclic risk.
•
Operational complexity from a multi-subsidiary model may incur higher compliance costs and ongoing administrative overhead.

Peers Summary

Sector Leader

Entero Healthcare Solutions Ltd. shows moderate growth and profitability compared to its peers, with the highest PBV and PE ratios indicating overvaluation. Adani Enterprises and Redington Ltd. emerge as strong competitors, benefitting from robust revenue growth and profitability, while the overall sector has a mix of strong and financially risky companies.

Key Points

• Entero has a high PE ratio (273.81), indicating overvaluation compared to peers.
• Adani Enterprises and Redington are strong performers with solid growth and profitability metrics.
• MMTC is financially weak with low revenue and high PE ratio, indicating risk.

Top Performers

Adani Enterprises Ltd.

Strong revenue growth (1.53% YoY), high ROE (9.477%) and attractive PEG (0.83) make it a top performer.

Redington Ltd.

Solid ROE (17.1182%) and low PE (13.20) indicate strong profitability and valuation attractiveness.

Explore

Watchlists

Command Palette